Paper42836780PubMed
Autoantibodies neutralizing type I interferons in COVID-19 patients from southern Brazil.
Sbruzzi RC and 17 others. J Hum Immun, 2026.
Cite this record
ConductScience Library. Autoantibodies neutralizing type I interferons in COVID-19 patients from southern Brazil. Papers, record 42836780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42836780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Autoantibodies neutralizing type I interferons in COVID-19 patients from southern Brazil.
- Journal
- J Hum Immun
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-08
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020-0479 | Hospital de Clínicas de Porto Alegre | PubMed | ||
| 518211/2020-00 | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | PubMed | ||
| 937823/2024-00 | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | PubMed | ||
| ANR-2021-RUS-008 | French National Research Agency | PubMed | ||
| 3110092025-5 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed |
Source PubMed
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36434007 | Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity. | Nat Commun | 2022 | https://conductscience.org/library/papers/36434007 | PubMed |
| 2 | 32972995 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. | Science | 2020 | https://conductscience.org/library/papers/32972995 | PubMed |
| 3 | 35419822 | Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity. | Eur J Immunol | 2022 | https://conductscience.org/library/papers/35419822 | PubMed |
| 4 | 35576468 | The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35576468 | PubMed |
| 5 | 36342455 | Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination. | J Exp Med | 2023 | https://conductscience.org/library/papers/36342455 | PubMed |
| 6 | 41623353 | Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV. | J Hum Immun | 2026 | https://conductscience.org/library/papers/41623353 | PubMed |
| 7 | 38129345 | Chest Computed Tomography Characteristics of Critically Ill COVID-19 Patients with Auto-antibodies Against Type I Interferons. | J Clin Immunol | 2023 | https://conductscience.org/library/papers/38129345 | PubMed |
| 8 | 34767118 | Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19. | J Clin Immunol | 2022 | https://conductscience.org/library/papers/34767118 | PubMed |
| 9 | 41332446 | Human immunity. | J Hum Immun | 2025 | https://conductscience.org/library/papers/41332446 | PubMed |
| 10 | 38547583 | Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening. | Heart Lung | 2024 | https://conductscience.org/library/papers/38547583 | PubMed |
| 11 | 34010947 | Diverse functional autoantibodies in patients with COVID-19. | Nature | 2021 | https://conductscience.org/library/papers/34010947 | PubMed |
| 12 | 37698062 | Examination of autoantibodies to type I interferon in patients suffering from long COVID. | J Med Virol | 2023 | https://conductscience.org/library/papers/37698062 | PubMed |
| 13 | 38193358 | Human autoantibodies neutralizing type I IFNs: From 1981 to 2023. | Immunol Rev | 2024 | https://conductscience.org/library/papers/38193358 | PubMed |
| 14 | 41394891 | Prevalence and association of type I IFN autoantibodies with clinical outcomes in critically ill Brazilian COVID-19 patients. | J Hum Immun | 2025 | https://conductscience.org/library/papers/41394891 | PubMed |
| 15 | 36113674 | Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19. | J Allergy Clin Immunol | 2022 | https://conductscience.org/library/papers/36113674 | PubMed |
| 16 | 37906115 | High Anti-Interferon-Alpha Autoantibody Levels in Severe/Critical COVID-19 Patients from Peru. | J Interferon Cytokine Res | 2023 | https://conductscience.org/library/papers/37906115 | PubMed |
| 17 | 38231281 | Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19. | J Clin Immunol | 2024 | https://conductscience.org/library/papers/38231281 | PubMed |
| 18 | 32405102 | A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection. | Cell | 2020 | https://conductscience.org/library/papers/32405102 | PubMed |
| 19 | 38226654 | Human genetic determinants of COVID-19 in Brazil: challenges and future plans. | Genet Mol Biol | 2024 | https://conductscience.org/library/papers/38226654 | PubMed |
| 20 | 34960822 | Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons. | Viruses | 2021 | https://conductscience.org/library/papers/34960822 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42836780
GET https://conductscience.org/api/papers/v1/42836780/references?page=2